Modulation of human monocyte CD36 by type 2 diabetes mellitus and other atherosclerotic risk factors

European Journal of Clinical Investigation

Volumn 41, Issue 8, 2011, Pages 854-862

  Bernal Lopez, Rosa M ^a,b   Llorente Cortes, Vicenta ^c   López Carmona, Dolores ^d   Mayas, Dolores M ^a,b   Gomez Huelgas, Ricardo ^b,d   Tinahones, Francisco J ^a,b   Badimon, Lina ^b,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Atherothrombosis; CD36; Diabetes; Hb1Ac; Monocytes

Indexed keywords

CD36 ANTIGEN; GLUCOSE; GLYCOSYLATED PROTEIN; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ANTIGEN EXPRESSION; ARTICLE; ATHEROSCLEROSIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GLYCATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPERTENSION; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTIGENS, CD36; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MONOCYTES; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 79960079361     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2011.02475.x     Document Type: Article

References (25)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (part I). N Engl J Med 1992;326:242-50.
2. Silverstein RL, Febbraio M. CD36 and atherosclerosis. Curr Opin Lipidol 2000;11:483-91.
3. Podrez E, Febbraio M, Sheibani N, Schmitt D, Silverstein RL, Hajjar DP et al. Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species. J Clin Invest 2000;105:1095-108.
4. Feng J, Han J, Pearce SF, Silverstein RL, Gotto AM Jr, Hajjar DP et al. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J Lipid Res 2000;41:688-96.
5. Griffin E, Re A, Hamel N, Fu C, Bush H, McCaffrey T et al. A link between diabetes and atherosclerosis: glucose regulates expression of CD36 at the level of translation. Nat Med 2001;7:840-6.
6. Liang CP, Han S, Okamoto H, Carnemolla R, Tabas I, Accili D et al. Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest 2007;113:764-73.
7. Yesner LM, Huh HY, Pearce SF, Silverstein RL. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler Thromb Vasc Biol 1996;16:1019-25.
8. Hoosdally SJ, Andress EJ, Wooding C, Martin CA, Linton KJ. The Human Scavenger Receptor CD36: glycosylation status and its role in trafficking and function. J Biol Chem 2009;284:16277-88.
9. Van Nieuwenhoven FA, Luiken JJ, De Jong YF, Grimaldi PA, Van der Vusse GJ, Glatz JF. Stable transfection of fatty acid translocase (CD36) in a rat heart muscle cell line (H9c2). J Lipid Res 1998;39:2039-47.
10. Greenwalt DE, Watt KW, So OY, Jiwani N. PAS IV, an integral membrane protein of mammary epithelial cells, is related to platelet and endothelial cell CD36 (GP IV). Biochemistry 1990;29:7054-9.
11. Tang Y, Taylor KT, Sobieski DA, Medved ES, Lipsky RH. Identification of a human CD36 isoform produced by exon skipping. Conservation of exon organization and pre-mRNA splicing patterns with a CD36 gene family member, CLA-1. J Biol Chem 1994;269:6011-5.
12. Febbraio M, Guy E, Silverstein RL. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler Thromb Vasc Biol 2004;24:2333-8.
13. Guy E, Kuchibhotla S, Silverstein R, Febbraio M. Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36o/apoEo mice. Atherosclerosis 2007;192:123-30.
14. Marleau S, Harb D, Bujold K, Avallone R, Iken K, Wang Y et al. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. FASEB J 2005;19:1869-71.
15. Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, Silver JM et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 2005;115:2192-201.
16. Ferreira V, van Dijk KW, Groen AK, Vos RM, van der Kaa J, Gijbels MJ et al. Macrophage-specific inhibition of NF-kappaB activation reduces foam-cell formation. Atherosclerosis 2007;192:283-90.
17. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
18. Schlenke P, Klüter H, Müller-Steinhardt M, Hammers HJ, Borchert K, Bein G. Evaluation of a novel mononuclear cell isolation procedure for serological HLA typing. Clin Diagn Lab Immunol 1998;5:808-13.
19. Llorente-Cortés V, Royo T, Otero-Viñas M, Berrozpe M, Badimon L. Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages. Cardiovasc Res 2007;74:526-36.
20. Collot-Teixeira S, Martin J, McDermott-Roe C, Poston R, McGregor JL. CD36 and macrophages in atherosclerosis. Cardiovasc Res 2007;75:468-77.
21. Handberg A, Skjelland M, Michelsen AE, Sagen EL, Krohg-Sørensen K, Russell D et al. Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability. Stroke 2008;39:3092-5.
22. Meng L, Park J, Cai Q, Lanting L, Reddy MA, Natarajan R. Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation. Am J Physiol Heart Circ Physiol 2010;298:H736-45.
23. Esper RJ, Vilariño JO, Machado RA, Paragano A. Endothelial dysfunction in normal and abnormal glucose metabolism. Adv Cardiol 2008;45:17-43.
24. Sampson MJ, Davies IR, Braschi S, Ivory K, Hughes DA. Increased expression of a scavenger receptor (CD36) in monocytes from subjects with Type 2 diabetes. Atherosclerosis 2003;167:129-34.
25. Huh HY, Pearce SF, Yesner LM, Schindler JL, Silverstein RL. Regulated expression of CD36 during monocyte-to-macrophage differentiation: potential role of CD36 in foam cell formation. Blood 1996;87:2020-8.